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Pathway databases are a means to systematically associate proteins with their functions and link them into
networks that describe the reaction space of an organism. Here, the Reactome Knowledgebase provides a
convenient example to illustrate strategies used to assemble such a reaction space based on manually
curated experimental data, approaches to semiautomated extension of these manual annotations to infer
annotations for a large fraction of a species’ proteins, and the use of networks of functional annotations to
infer pathway relationships among variant proteins that have been associated with disease risk through
genome-wide surveys and resequencing studies of tumors.A reductionist but compelling view of the physiology of a cell is
that it is fully determined by the properties of its parts: a catalog
of its molecules and their functions is sufficient to specify its
behavior and feedback loops and regulatory interactions speci-
fied in the catalog allow inference of responses to external stimuli
at the cellular level. Proteins, the key components of this parts
list, can be comprehensively cataloged. Accurate genomic
DNA sequences exist for many species, including humans.
High-throughput tools for identifying messenger RNAs and pro-
teins, combined with computational tools for identifying open
reading frames in a genomic DNA sequence, provide near-com-
plete lists of the proteins a genome can encode (ENCODE
Project Consortium, 2012). A variety of technologies provide
views of the proteins actually present in specific tissues and their
changes as a function of tissue state (Uhlen et al., 2010). DNA
resequencing projects are beginning to support inference of
comprehensive catalogs of individual variations in protein
sequences (e.g., Tennessen et al., 2012 and 1000 Genomes
Project Consortium, 2012). But these protein lists do not explain
an organism’s functions. Explanation requires a wiring diagram
that embodies functional information: what components interact
with what other ones and with what consequences. Interactions
can include transformations of molecules, including changes in
chemical structure and location, and association of proteins
and other molecules to form complexes with novel properties.
A pathway database captures these functional relationships
among the molecular parts of a cell.
A variety of pathway databases have been developed in the
past decade, notably HumanCyc (Romero et al., 2005), Kyoto
Encyclopedia of Genes and Genomes (KEGG) (Kanehisa et al.,
2012), National Cancer Institute-Pathway Interaction Database
(NCI-PID) (Schaefer et al., 2009), Panther (Mi et al., 2013), and
Reactome (Croft et al., 2011). Features of broadly useful pathway
databases are emerging. Capturing the diverse functions of a cell
in a single consistent representation is critical. For example, a
hormone binds a cell-surface receptor, setting off a cascade of
phosphorylation events, some of which activate or inactivate
proteins already in the cell, while others activate transcription
factors, causing synthesis of proteins not previously present.Chemistry & BThe changed array of active proteins in turn might switch the
cell from synthesizing and storing energy-rich molecules to
breaking them down or from a dividing state to a nondividing
one. For this description to capture a cell’s normal behavior or
predict its response to a stress, like amutational change in a pro-
tein’s function or the presence of a novel small molecule in its
environment, the description must be comprehensive and inter-
nally consistent. A single vocabulary is needed to describe
biochemical transformations of small molecules, binding and
transport events, and signal transduction. The description
should also account for location. Cells are not homogeneous;
the same molecule in different subcellular locations can have
entirely different fates.
Organization and Content of a Pathway Database
The problem of representing diverse physical entities andmolec-
ular functions in a consistent and detailed way can be illustrated
by human ‘‘Hippo’’ signaling and linked processes that regulate
the Yes-associated protein 1 (YAP1) andWW domain containing
transcription regulator 1 (WWTR1) transcription factors (Figure 1).
In their unphosphorylated states, cytosolic YAP1 and WWTR1
can be taken up into the nucleus and function as transcriptional
coactivators for an array of genes that promote cell proliferation.
In their phosphorylated states, YAP1 and WWTR1 are instead
sequestered in the cytosol. Phosphorylation is mediated by the
three-step Hippo kinase cascade, first described in Drosophila
(Oh and Irvine 2010). There are two human homologs of each
of the Drosophila kinases. Autophosphorylated STK3 (MST2)
and STK4 (MST1) (homologs of Drosophila Hippo) catalyze the
phosphorylation and activation of LATS1 and LATS2 and of the
accessory proteins MOB1A and MOB1B. LATS1 and LATS2, in
turn, catalyze the phosphorylation of the transcriptional coacti-
vators YAP1 and WWTR1 (TAZ). Several accessory proteins
are required for the kinase cascade. STK3 (MST2) and STK4
(MST1) each form a complex with SAV1, and LATS1 and
LATS2 form complexes with MOB1A and MOB1B.
Additional processes can modulate YAP1 and WWTR1
activity. Caspase 3 protease cleaves STK3 (MST2) and STK4
(MST1), releasing inhibitory carboxyterminal domains fromiology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 629
Figure 1. Human Hippo Signaling Pathway
Kinase cascade components STK, LATS, MOB,
and SAV1 interact, leading to the phosphorylation
and cytosolic sequestration of YAP and WWTR1
transcription factors. Caspase 3 may activate this
process by cleaving STK3, increasing its kinase
activity. Cytosolic sequestration of YAP and
WWTR1 may also be mediated by AMOT and ZO
proteins.
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phosphorylation (Lee et al., 2001). Also, cytosolic AMOT and ZO
proteins can bind YAP1 and WWTR1 in their unphosphorylated
states to form complexes that are sequestered in the cytosol
(Chan et al., 2011; Oka et al., 2010; Remue et al., 2010).
To represent processes like these, a datamodel is needed that
can classify and catalog physical entities (e.g., proteins and
other macromolecules, small molecules, complexes of these
entities, and posttranslationally modified forms of them), the
transformations they can undergo (e.g., biochemical reaction,
association to form a complex, and translocation from one
cellular compartment to another), and their subcellular locations.
It is convenient to provide an overview of these features as they
are implemented in the Reactome data model (Vastrik et al.,
2007), which builds on earlier work by Kanehisa (2000) and
Karp et al. (1999) (Figure 2). A more rigorous data model specifi-
cation is available in documentation linked to the Reactome web
site (http://www.reactome.org).
Formally, the data model is a list of classes and subclasses,
notably a physical entity class with protein, small molecule,
and complex subclasses and an event class with reaction and
pathway subclasses. Each class has a set of attributes that iden-
tify individual class members (instances) and distinguish them
from one another.
For the protein class, attributes include the protein’s name,
length, covalent modifications if any, and subcellular location.630 Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reservedPhosphorylated STK3, for example, is
491 residues in length with a phosphate
group attached to the side chain hydroxyl
group of threonine residue 180 and is
cytosolic. Different instances are created
not only for different proteins (STK3
versus caspase 3) but for forms of the
same protein that differ in their locations
or covalent modifications.
Changes in the amino acid sequence of
a protein due to mutation can be repre-
sented as a kind of covalent modification
by identifying the affected residue in the
protein and the replacement amino acid
residue (Milacic et al., 2012).
For the complex class, attributes are
the proteins and small molecules that
form the complex, the numbers of copies
of each if known, and a subcellular loca-
tion. The p-STK3:p-SAV1 complex, for
example, consists of two copies of the
full-length form of each protein, each
covalently modified by phosphorylation(STK3 at residue 180, SAV1 at an unknown residue) located in
the cytosol.
A reaction’s attributes are its substrates (inputs), products
(outputs), location, and, when appropriate, a catalyst and one
or more regulators. Inputs and outputs are physical entities
(i.e., protein, small molecule, and complex instances). Catalysts
are annotated by creating instances of a catalyst-activity class
with two key attributes: a physical entity and its activity described
with a molecular function term from the Gene Ontology (GO)
(Ashburner et al., 2000; Gene Ontology Consortium, 2010). For
example, the proteolytic cleavage of the p-STK3 component of
the pSTK3:p-SAV1 is represented by a reaction instance that
has the intact complex as input, a new complex consisting of
intact p-SAV1 and the amino-terminal portion of p-STK3 plus
the free carboxyterminal portion of p-STK3 as outputs, a cyto-
solic location, and an associated catalyst-activity that has
cytosolic caspase-3 as its physical entity and ‘‘cysteine-type
endopeptidase activity’’ as its catalyst activity. If one wanted to
annotate the effect of a drug that accelerated the reaction by
increasing caspase-3 activity, one could create an instance of
the regulation class with the drug as its regulator attribute and
the cleavage reaction as its regulated-event attribute.
A transport reaction instance would have the cargo entity in its
initial location as input, the same molecular entity but in its final
location, hence, a different physical-entity instance in the data
model, as output, and a ‘‘catalyst-activity’’ instance containing
Figure 2. Schematic View of Reactome Data Model
Relationships of event and physical entity classes to one another and to
external reference databases and ontologies are shown.
Chemistry & Biology
Perspectivethe protein or complex that acted as a transporter or channel
plus a GO molecular-function transport activity term. Binding
reactions to form complexes are annotated simply with small
molecules, protein monomers, or subcomplexes as inputs and
the complex as output.
A pathway instance has as its attributes a list of the reactions
that comprise it and an appropriate descriptive term from the GO
biological process-ontology.
To annotate the experimental evidence that supports these
assertions about the properties of physical entities, events,
and catalytic and regulatory activities, all of these classes have
two additional attributes: one for literature references and one
for a free-text summary.
This annotation strategy can readily capture disease pro-
cesses by supporting the annotation of variant physical entities
formed by mutated proteins, activities of biological toxins, and
regulatory effects of xenobiotic molecules (Milacic et al., 2012).
The annotation of alternative locations, posttranslational
modifications and genetic variations, and conformations of a
molecule causes instances of a physical entity to proliferate.
The basic chemical information that all forms share is stored in
a separate class of reference (canonical) physical entities,
explicitly linking all the alternative forms of a single entity. The
attributes of a reference entity include its name, reference chem-
ical structure or sequence, and its accession numbers in widely
used reference databases: Universal Protein Resource for pro-
teins (UniProt Consortium, 2012), Chemical Entities of Biological
Interest for small molecules (de Matos et al., 2010), and Ensembl
for nucleic acids (Flicek et al., 2012; Figure 2).
These annotations can be visualized as Systems Biology
Graphical Notation (SBGN)-like (Le Nove`re et al., 2009) diagrams
(Figure 3A), in which physical entity icons are connected by reac-
tion edges and displayed in a web environment that allows
access to annotation details of the entities and events (Croft
et al., 2011). As of March 2013, 6,977 human proteins have
been annotated and associated with 6,198 reactions involving
1,347 small molecules, backed by evidence gathered from
13,588 literature references. The reactions span biological
processes that include metabolism, core events of molecular
biology, signaling and transport processes, and specialized pro-
cesses, such as blood coagulation and neuronal guidance. In
these respects, Reactome, like HumanCyc, KEGG, NCI-PID,Chemistry & Band PANTHER, provides an extensive but incomplete set of
data, linking many human proteins to qualitative specifications
of their functions.
Inference from Annotated Physical Entities and
Reactions to Functional Descriptions of Whole
Proteomes
This description of a manually curated pathway database raises
two major issues. First, how can the annotation process used so
far be scaled up and extended? The human genome encodes on
the order of 22,000 proteins. How can the remaining two-thirds
of them be annotated, and how can the full range of functions
for each be captured? Can this process be extended to other
species as their genome sequences and predicted protein sets
are generated? Second, these annotations represent an archive
of known relationships among proteins and other cellular com-
ponents. Can they be used to discover novel relationships and
thereby convert an archive of well-characterized proteins and
their functions into a tool for exploring possible novel functions
and relationships of these and other proteins? Recent work sug-
gests promising approaches to both of these issues, and the
remainder of this perspective will focus on them. Again, discus-
sion will center on Reactome and, again, it is important to note
that this focus is a matter of convenience—the approaches are
generalizable.
Manual annotation is labor-intensive: the 7,000 human
proteins and 6,200 reactions involving them now annotated in
Reactome are the product of several years’ work, and the rate
of manual annotation is a nearly linear function of the number
of skilled curators at work and the level of accuracy and detail
expected. How can a manually built framework be used to orga-
nize larger bodies of information automatically or semiautomat-
ically within and between species?
Inferences from Annotated Proteins to Protein Families
Several strategies are widely used to group proteins into families
based on sequence similarity (e.g., Altschul et al., 1997 and Finn
et al., 2011). These strategies can be applied to identify unanno-
tated human proteins likely to share a functional property of in-
terest with an annotated one. Specifically, sequence alignment
strategies that combine requirements for a moderate level of
overall sequence similarity with perfect conservation (identity
and spacing) of key amino acid residues show very high speci-
ficity when applied to identify members of enzyme families with
conserved substrate specificity. In a preliminary analysis of
enzymes mediating reactions of intermediary metabolism cata-
loged in Reactome, 110 instances have been found, in which a
reaction said to be catalyzed by a well-studied enzyme can be
reannotated to be catalyzed by any one of a set of up to ten
candidate enzymes. Work is underway to validate these obser-
vations and to extend the analysis to additional enzymes and
potentially to transport proteins. An intriguing observation is
that, in several cases, a single enzyme has been identified as a
candidate catalyst of more than one reaction, suggesting that
this strategy might be useful not only to bring more proteins
into an existing reaction network but also to extend the connec-
tivity of that network.
Sequence similarity among proteins is also widely used to
predict functions of an uncharacterized protein in a species ofiology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 631
Figure 3. Visualization of Curated Components of Pathways and Inferred Interacting Proteins and Small Molecules
(A) A diagram of the Hippo/STK signaling pathway as annotated in Reactome, using SBGN-like iconography to display proteins and complexes (rectangles) and
small molecules (ovals) connected by reaction edges that distinguish inputs (plain end), outputs (arrowhead end), and catalysis (open-circle end) as well as
reaction type (open box reaction node, chemical transformation; closed circle, binding).
(B) A portion of the manually annotated pathway is enlarged and overlaid with proteins found in high-throughput surveys (Wu et al., 2010) to interact with Hippo
pathway components STK3 (MST2), STK4 (MST1), or both.
(C) The manually annotated pathway is overlaid with small molecules from the ChEMBL database (Gaulton et al., 2012) that bind STK3 (MST2), STK4 (MST1),
or both.
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The complete protein sets predicted from whole genome
sequencing for many species support this inference process
but also complicate it by forcing investigators to sort out com-
plex subfamily structural relationships within and between spe-
cies in order to infer likely functional relationships (Koonin,
2005). A promising recent approach has been developed by a
group of investigators associated with the Gene Ontology
project to extend annotation in a semiautomated fashion to a
collection of reference genomes (Gaudet et al., 2011). Briefly, a
sequence alignment is assembled for each protein family from
the predicted complete protein sets for all of the species to be
annotated. The alignment is organized to display both similarity
relationships among the proteins and evolutionary relationships
among the species, and each sequence is tagged with any
molecular functions that have been established for it experimen-
tally. Where different family members have different present-day
functions in well-studied species, these can be traced back
through the phylogenetic relationships in the alignment to iden-
tify the likely ancestral point at which gene duplication gave
rise to the genes that subsequently diverged to take on these
distinct current functions or a mutation in a single gene caused
a change in function that has been passed on to present-day
species in that branch of the phylogeny. This, in turn, allows
parsimonious inferences of likely functions for present-day
members of the protein family for all of the species.
Extending Annotations with Computationally Inferred
Protein-Protein Pairs
Many high-throughput strategies have been used to catalog
pairwise protein-protein interactions—co-occurrence in immune632 Chemistry & Biology 20, May 23, 2013 ª2013 Elsevier Ltd All righprecipitates, interaction in yeast two-hybrid screens, coannota-
tion with the same specific GO term, and others. Wu et al. (2010)
have developed a strategy to use such pairwise interac-
tions between already annotated proteins and previously
unknown ones to incorporate the latter into pathway data-
bases. They have assembled many pairwise-interaction data
sets and designed a naive Bayes classifier, trained on vali-
dated protein-protein functional interaction data, to assign a
quality score to each pairwise interaction. Any one pair of
proteins might thus have interaction scores from one or
several sources. Whenever a pair involves one protein that
has been manually curated and associated with pathways
and one that has not been curated, the uncurated protein can
be associated with the annotated one (Figure 3B). Evidence
for the association can be provided as a tabulation of all
of the high-throughput data, from which the protein-protein
interaction was inferred (Figure 4). In aggregate, these pairings
identify approximately 5,000 unannotated human proteins as
candidates for involvement with one or more Reactome
pathways.
These interactors can be visualized as coronas decorating the
annotated proteins in pathway diagrams. The version of this
analysis and display tool implemented in the Reactome web
site enables decoration of pathways with interactions from pre-
computed data sets or with custom pairwise-interaction data
sets generated by users. In the example shown in Figure 3B, pre-
computed data are used to highlight groups of proteins that
interact with each of STK3 (MST2) and STK4 (MST1) proteins
in the Hippo signaling pathway and a smaller number that
interact with both. The observation of a set of interactors not
known to be involved in the Hippo signaling process must bets reserved
Figure 4. Clustering Genes with Functional Information from Curated and Inferred Pathway Database Content
Seventy-nine genes whose variants are associated with clinically important red blood cell phenotypes in humans (circles) (van der Harst et al., 2012), together with
55 genes identified as their functional interactors (diamonds) are grouped into ten modules with an edge-betweenness strategy (Wu et al., 2010). Modules are
distinguished by color, manually annotated interactions between gene products are shown as solid lines, inferred pairwise interactions are shown as dotted lines,
arrowheads indicate activation or catalysis, and T-bars indicate inhibition. The largest module (34 total nodes, 16 linkers) is enlarged, and the inset shows the
quality scores for the inferred pairwise functional interaction between TAL1 (RBC variant gene) and HDAC2 (linker).
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imentally testable hypothesis identifying a set of proteins that
might be functional links between Hippo signaling and other pro-
cesses, and, in two cases, between different arms of the Hippo
signaling process itself.
The same logic can be applied to display interactions between
proteins and small molecules. In Figure 3C, the interactions of
STK3 (MST2) and STK4 (MST1) proteins with small molecules
cataloged in the ChEMBL database (Gaulton et al., 2012) are
shown. Again, the display suggests the intriguing speculation
that it might be possible to find drugs to modulate two arms of
this pathway independently.
Discovering Functional Networks in SomaticMutant and
GWAS Gene Sets
Functionally interacting protein-protein pairs can not only be
used to extend manual annotation to suggest related proteins,
it can also be applied to sets of genes identified in large-scale
screens, such as those carried out in connection with the Can-
cer Genome Atlas project. Working with sets of recurrently
mutated genes from several tumor types identified in that proj-
ect, Wu et al. (2010) have identified, for each data set/tumor
type they examined, sets of related genes (e.g., all involved in
signaling or in cell cycle regulation) composed of recurrentlyChemistry & Bmutated genes linked via functional protein-protein interac-
tions. This was done without applying prior information about
gene function.
Here, this strategy for data analysis has been applied to a set
of 121 genes whose polymorphism has been linked to clinically
important red blood cell phenotypes in a group of genome-
wide association studies (GWASs) (van der Harst et al., 2012).
Use of the edge-betweenness strategy described by Wu et al.
(2010) to cluster these genes based on shared functional proper-
ties yields only a few small clusters. When other genes identified
as pairwise interactors of the 121 are added to the collection,
however, 79 of the 121 are grouped with 55 linker genes into
ten modules, the largest of which contains 18 genes identified
in the GWAS and 16 linkers from the pairwise interactor set
(Figure 4). Thewell-studied genes in this cluster play related roles
in DNA replication and transcription, suggesting similar roles for
other genes brought into the cluster by this analysis. While these
processes take place in all nucleated cells, it is a reasonable hy-
pothesis that their precise quantitative regulation is especially
critical in any developing tissue and perhaps especially so in a
system like erythropoiesis, where very large numbers of cells
containing large but precisely controlled amounts of alpha-
and beta-globin proteins must be generated at a high basal
rate and with regulated responses to environmental stresses,iology 20, May 23, 2013 ª2013 Elsevier Ltd All rights reserved 633
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also identifies, in the set of linker genes, attractive targets for as-
sociation studies and large-scale resequencing studies aimed at
identifying rare genetic variants that might have strong pheno-
typic effects.
Conclusions
This perspective, using a single pathway database as a conve-
nient model, has attempted to show the value of such data
structures generally. These databases are becoming widely
useful on-line archives that allow experimental data detailing
the molecular functions of proteins to be organized in a useful,
consistent format that supports computational mining and
querying. Several recently developed tools for analysis of
protein-protein pairs defined by high-throughput assays and
for the analysis of functional relationships suggested by the
organization of sequence-based protein families appear likely
to support efficient extension of manual annotations to cover
a large fraction of the human proteome and perhaps the
proteomes of other species. Other tools allow the use of a
pathway archive as the starting point for identifying possible
functional relationships among genes identified, because vari-
ants of them are disease risk factors. In all of these ways,
pathway databases appear ready to grow beyond their role as
repositories for well-established data and to take on a central
role in experiments to work out the functional architecture of
whole proteomes.
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